Effect of Donepezil on the Reorganization of Cognitive Neural Network in Patients With Post-Stroke Cognitive Impairment

NCT00530478 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-09-17

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the efficacy and safety of donepezil on the recovery of cognitive function in patients with stroke and to delineate the neurophysiologic mechanisms of the therapeutic effect of donepezil on the recovery of cognitive network using functional neuroimaging technique.

Conditions

Interventions

DRUG

Donepezil

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Suk Hoon Ohn, MD, MS · Samsung Medical Center

  • Yun Hee Park, MD · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00530478 on ClinicalTrials.gov